Arzeda Corp
Seattle, WA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3421 Thorndyke Ave W, Seattle, WA 98119, USA
- Website
- arzeda.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $389,351 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Computational design of enzymatic prophylactics and/or therapeutics for chemical warfare nerve agents | Defense Threat Reduction Agency | $1,507,784 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Arzeda Corp is a biotechnology company based in Seattle, Washington, specializing in artificial intelligence-driven enzyme design and synthetic biology solutions. The company focuses on developing advanced enzymatic technologies that can transform industrial processes, with a particular emphasis on sustainable chemical production, carbon conversion, and innovative biomanufacturing techniques. Through federal contract and grant awards, Arzeda provides cutting-edge research and development services in areas including enzymatic design, bioconversion technologies, and advanced protein engineering.
For federal contract work, Arzeda has been awarded a significant Small Business Innovation Research (SBIR) Phase II contract from the Defense Threat Reduction Agency (DTRA). This $1,507,783.93 contract, awarded in August 2022, focuses on computational design of enzymatic prophylactics and therapeutics specifically targeting chemical warfare nerve agents. The contract is set aside for small businesses and represents a definitive, firm-fixed-price research effort with a completion date of August 28, 2025. The work demonstrates Arzeda's capabilities in developing sophisticated enzymatic solutions for national defense and security applications.
In the federal grant arena, Arzeda has secured multiple substantial cooperative agreements from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships program. These awards include a $2,526,095 project to develop cell-free enzymatic systems for converting carbon dioxide into methanol using electricity, and a $2,233,515 project aimed at creating a biocatalytic process for producing bio-based acrylate monomers. Additionally, the company received a grant from the Office of Science for research on enzymatic degradation and upcycling of polyamides. These grants highlight Arzeda's expertise in AI-driven enzyme design, sustainable chemical production, and advanced biotechnology research, with a strong focus on developing innovative solutions for carbon utilization, industrial chemical production, and environmental sustainability.
Quick answers
Is Arzeda Corp registered in SAM.gov?
Yes. Arzeda Corp's SAM.gov registration is active through December 12, 2026.
What is Arzeda Corp's CAGE code?
Arzeda Corp's CAGE code is 5GK43, and its Unique Entity ID (UEI) is KNSJJT2DJNS1.
How much has Arzeda Corp received in federal contracts?
Federal contracts obligated $389,351 to Arzeda Corp in fiscal year 2025.
What is Arzeda Corp's most recent federal award?
Arzeda Corp's most recent federal grant award is Ideas lab: cfire: electricity-driven cell-free cascades (2453663), from National Science Foundation, on May 1, 2025.
On GovTribe
See Arzeda Corp's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors